₹687.50
as on
as on September 4, 2025 at 4:01 pm IST
Day's Low
Day's High
1.09%
Downside
3.71%
Upside
52 Week's Low
52 Week's High
45.65%
Downside
48.05%
Upside
as on September 4, 2025 at 4:01 pm IST
Market Cap
₹581.81 Cr
Return on Equity (ROE)
13.36
PE Ratio (TTM)
26.46
Return on capital employed (ROCE)
17.49
Industry PE ratio
42.24
Beta (LTM)
0.79
P/B Ratio
3.4
Dividend Yield
0.38
PEG Ratio
-7.06
Quarterly Earnings Growth YOY
8.07
EPS (TTM)
22.11
Sector
Pharmaceuticals
Book Value
185.64
Technical Analysis
Bullish
View Technical Analysis
as on September 4, 2025 at 4:01 pm IST
Titan Biotech Ltd in the last 5 years
Lowest (3.20x)
June 30, 2020
Today (26.46x)
September 3, 2025
Industry (42.24x)
September 3, 2025
Highest (32.11x)
October 21, 2024
Today’s Price to Earnings Ratio: 26.46x
Compare market cap, revenue, PE, and other key metrics of Titan Biotech Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 581.81 | 69.69% | 0.53 | 18 | 156 | |
BUY | 16,426.13 | 61.13% | 0.51 | 461 | 1,694 | |
BUY | 5,234.08 | 13.79% | 0.63 | 128 | 1,243 | |
NA | 2,303.77 | 7.5% | 0.00 | 100 | 390 | |
NA | 7,969.18 | 41% | 0.57 | 216 | 1,852 |
Search interest for Titan Biotech Ltd Stock has increased by 208% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:208% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
Numbers in percentages
View detailed summary of the earnings and dividend history of Titan Biotech Ltd.
Titan Biotech Ltd’s net profit jumped 7.19% since last year same period to ₹6.86Cr in the Q1 2025-2026. On a quarterly growth basis, Titan Biotech Ltd has generated 69.38% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Titan Biotech Ltd has declared dividend of ₹2.00 per share on 29 May 2024 - translating a dividend yield of 0.54%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 1 month, Titan Biotech stock has moved up by 54.7%
Best in 1 Year
In the last 1 year, Titan Biotech has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Profit Spike
Netprofit is up for the last 2 quarters, 4.05 Cr → 6.86 Cr (in ₹), with an average increase of 41.0% per quarter
Revenue Rich
Revenue is up for the last 2 quarters, 36.55 Cr → 47.22 Cr (in ₹), with an average increase of 22.6% per quarter
Best in 3 Years
In the last 3 years, Titan Biotech has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Promoter Holding Unchanged
Promoters holdings remained unchanged at 55.88% of holdings in Jun 2025 quarter
Retail Holding Down
Retail Investor have decreased holdings from 44.11% to 44.09% in Jun 2025 quarter
Organisation | Titan Biotech Ltd |
Headquarters | New Delhi |
Industry | Pharmaceuticals |
CEO | Rohit Jain |
E-voting on shares | Click here to vote |
Titan Biotech Ltd share price today stands at ₹687.5 as on at the close of the market. Titan Biotech Ltd share today touched a day high of ₹713 and a low of ₹680.
Titan Biotech Ltd touched a 52 week high of ₹1017.85 and a 52 week low of ₹373.65. Titan Biotech Ltd share price today i.e. is closed at ₹687.5, which is -32.46% down from its 52 week high and 84.00% up from its 52 week low.
Titan Biotech Ltd market capitalisation is ₹581.81 Cr as on .
To buy Titan Biotech Ltd shares, you need to follow these steps:
Titan Biotech Ltd trading volume is 8,676.00 as on . This means that 8,676.00 shares of Titan Biotech Ltd were bought and sold on the stock market during today's trading session.